STOCK TITAN

[Form 4] INTERNATIONAL ISOTOPES INC Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

International Isotopes Inc. (INIS) reported a director received a stock option grant. On 10/10/2025, the reporting person was awarded 500,000 stock options at an exercise price of $0.06 per share, recorded with transaction code A.

The options are first exercisable on 07/11/2026 and expire on 10/10/2035. Following this transaction, the reporting person beneficially owned 500,000 derivative securities, held directly.

International Isotopes Inc. (INIS) ha riferito che un amministratore ha ricevuto una concessione di stock option. Il 10/10/2025, la persona che segnala ha ricevuto 500.000 stock option a un prezzo di esercizio di $0,06 per azione, registrata con il codice di transazione A.

Le opzioni sono immediatamente exercitabili il 07/11/2026 e scadono il 10/10/2035. A seguito di questa transazione, la persona che segnala possedeva beneficiamente 500.000 strumenti derivati, detenuti direttamente.

International Isotopes Inc. (INIS) informó que un director recibió una asignación de opciones sobre acciones. El 10/10/2025, la persona reportante recibió 500,000 opciones sobre acciones a un precio de ejercicio de $0.06 por acción, registrada con el código de transacción A.

Las opciones son exercitables por primera vez el 07/11/2026 y expiran el 10/10/2035. Tras esta transacción, la persona reportante poseía de manera beneficiosa 500,000 valores derivados, mantenidos directamente.

International Isotopes Inc. (INIS)는 이사가 주식 옵션 부여를 받았다고 보고했습니다. 2025년 10월 10일, 보고자는 500,000주 옵션$0.06의 행사 가격으로 받았으며 거래 코드 A로 기록되었습니다.

옵션은 최초로 2026년 7월 11일에 행사 가능하며 2035년 10월 10일에 만료됩니다. 이 거래 이후 보고자는 500,000개의 파생증권직접 소유하고 있었습니다.

International Isotopes Inc. (INIS) a indiqué qu'un administrateur a reçu une attribution d'options d'achat d'actions. Le 10/10/2025, la personne déclarante s'est vu attribuer 500 000 options d'achat d'actions à un prix d'exercice de $0,06 par action, enregistrée avec le code de transaction A.

Les options peuvent être exercées pour la première fois le 11/07/2026 et expirent le 10/10/2035. Suite à cette transaction, la personne déclarante détenait de manière utile 500 000 titres dérivés, détenus directement.

International Isotopes Inc. (INIS) meldete, dass ein Direktor eine Aktienoptionszuteilung erhalten hat. Am 10.10.2025 wurde der meldenden Person 500.000 Aktienoptionen zu einem Ausübungspreis von $0,06 pro Aktie zugeteilt, registriert mit dem Transaktionscode A.

Die Optionen sind erstmals am 07/11/2026 ausübbar und laufen am 10/10/2035 ab. Nach dieser Transaktion hielt die meldende Person vorteilhafterweise 500.000 Derivatewerte, direkt gehalten.

International Isotopes Inc. (INIS) أفاد بأن مديراً تلقى منحة خيارات الأسهم. في 10/10/2025، تم منح الشخص المبلغ عنه 500,000 خيار أسهم بسعر ممارسة $0.06 للسهم، مسجلاً برمز المعاملة A.

يمكن ممارسة الخيارات لأول مرة في 07/11/2026 وتنتهي صلاحيتها في 10/10/2035. عقب هذه المعاملة، أصبح الشخص المبلغ عنه يملك بشكل مستفيد 500,000 ورقة مشتقة، بشكل مباشر.

国际同位素公司 (INIS) 报告称,一位董事收到了股票期权授予。2025/10/10,报告人获得了50万股股票期权,行权价为每股$0.06,交易代码为 A。

这些期权最早可在2026/07/11行使,并于2035/10/10到期。此交易后,报告人实际持有50万份衍生证券,直接持有。

Positive
  • None.
Negative
  • None.

International Isotopes Inc. (INIS) ha riferito che un amministratore ha ricevuto una concessione di stock option. Il 10/10/2025, la persona che segnala ha ricevuto 500.000 stock option a un prezzo di esercizio di $0,06 per azione, registrata con il codice di transazione A.

Le opzioni sono immediatamente exercitabili il 07/11/2026 e scadono il 10/10/2035. A seguito di questa transazione, la persona che segnala possedeva beneficiamente 500.000 strumenti derivati, detenuti direttamente.

International Isotopes Inc. (INIS) informó que un director recibió una asignación de opciones sobre acciones. El 10/10/2025, la persona reportante recibió 500,000 opciones sobre acciones a un precio de ejercicio de $0.06 por acción, registrada con el código de transacción A.

Las opciones son exercitables por primera vez el 07/11/2026 y expiran el 10/10/2035. Tras esta transacción, la persona reportante poseía de manera beneficiosa 500,000 valores derivados, mantenidos directamente.

International Isotopes Inc. (INIS)는 이사가 주식 옵션 부여를 받았다고 보고했습니다. 2025년 10월 10일, 보고자는 500,000주 옵션$0.06의 행사 가격으로 받았으며 거래 코드 A로 기록되었습니다.

옵션은 최초로 2026년 7월 11일에 행사 가능하며 2035년 10월 10일에 만료됩니다. 이 거래 이후 보고자는 500,000개의 파생증권직접 소유하고 있었습니다.

International Isotopes Inc. (INIS) a indiqué qu'un administrateur a reçu une attribution d'options d'achat d'actions. Le 10/10/2025, la personne déclarante s'est vu attribuer 500 000 options d'achat d'actions à un prix d'exercice de $0,06 par action, enregistrée avec le code de transaction A.

Les options peuvent être exercées pour la première fois le 11/07/2026 et expirent le 10/10/2035. Suite à cette transaction, la personne déclarante détenait de manière utile 500 000 titres dérivés, détenus directement.

International Isotopes Inc. (INIS) meldete, dass ein Direktor eine Aktienoptionszuteilung erhalten hat. Am 10.10.2025 wurde der meldenden Person 500.000 Aktienoptionen zu einem Ausübungspreis von $0,06 pro Aktie zugeteilt, registriert mit dem Transaktionscode A.

Die Optionen sind erstmals am 07/11/2026 ausübbar und laufen am 10/10/2035 ab. Nach dieser Transaktion hielt die meldende Person vorteilhafterweise 500.000 Derivatewerte, direkt gehalten.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Laflin Steve

(Last) (First) (Middle)
4137 COMMERCE CIRCLE

(Street)
IDAHO FALLS ID 83401

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
INTERNATIONAL ISOTOPES INC [ INIS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/10/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) $0.06 10/10/2025 A 500,000 07/11/2026 10/10/2035 Common Stock 500,000 $0 500,000 D
Explanation of Responses:
/s/ Shahe Bagerdjian, Attorney-in-fact 10/15/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
International Isotopes

OTC:INIS

INIS Rankings

INIS Latest News

INIS Latest SEC Filings

INIS Stock Data

31.69M
141.35M
73.24%
0%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
Idaho Falls